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Neurotoxic Effects of Subchronic Intratracheal Mn Nanoparticle Exposure Alone and in 
Combination with Other Welding Fume Metals in Rats 
Manganese (Mn) is a toxic heavy metal exposing workers in various occupational 
settings and causing, among others, nervous system damage. Metal fumes of welding, a 
typical source of Mn exposure, contain a complex mixture of metal oxides partly in 
nanoparticle form. As toxic effects of complex substances cannot be sufficiently 
understood by examining its components separately, general toxicity and functional 
neurotoxicity of a main pathogenic welding fume metal, Mn, was examined alone and 
combined with iron (Fe) and chromium (Cr), also frequently found in fumes. Oxide 
nanoparticles of Mn, Mn + Fe, Mn + Cr and the triple combination were applied, in 
aqueous suspension, to the trachea of young adult Wistar rats for 4 weeks. The decrease 
of body weight gain during treatment, caused by Mn, was counteracted by Fe, but not 
Cr. At the end of treatment, spontaneous and evoked cortical electrical activity was 
recorded. Mn caused a shift to higher frequencies, and lengthened evoked potential 
latency, which were also strongly diminished by co-application of Fe only. The 
interaction of the metals seen in body weight gain and cortical activity were not related 
to the measured blood and brain metal levels. Fe might have initiated protective, e. g. 
antioxidant, mechanisms with a more general effect. 
Keywords: nanoparticle, neurotoxicity, welding fume, rat, intratracheal 
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Introduction 
Mn is an essential micronutrient for humans and for all living organisms, required, among 
others, for the development and the normal function of the central nervous system (CNS; 
Elder et al. 2006). When overdosed, however, first of all for longer periods, it acts as a 
neurotoxicant. The human disease caused by chronic exposure to higher doses, called 
manganism (Saric et al. 1977; Calne et al. 1994) leads to a Parkinson-like end stage. 
Electrophysiological signs of CNS damage, seen after welding-related occupational 
Mn exposure, include myoclonus in welders (Ono et al. 2002) as well as 
electroencephalogram (EEG) and evoked potential (EP) alterations (Sinczuk-Walczak et al. 
2001). 
Oxidative stress is apparently a major feature of Mn neurotoxicity. This includes 
mitochondrial toxicity (inhibition of complex II and III: Malecki 2001; Zhang et al. 2003), 
oxidation of dopamine and other catecholamines (Mn is accumulated in dopamine-rich brain 
regions, especially in the basal ganglia: Erikson and Aschner 2003) and decreased activity of 
Mn-SOD and glutathion peroxidase (HaMai and Bondy 2004). In rats, increased lipid 
peroxidation was found after one month of oral Mn exposure, and was linked to decreased 
motility (Avila et al. 2008).  
Previous own studies on the neurotoxicity of Mn revealed, as the main 
electrophysiological alteration in rats, a latency lengthening of cortical sensory EPs, observed 
after several weeks of Mn exposure by the oral route (dissolved MnCl2: Vezér et al. 2005) or 
by intratracheal application of dissolved (Máté et al. 2011) or nanoparticulate Mn (MnO2 
nanoparticles (NPs): Oszlánczi et al. 2010). Parallel shift of the spontaneous cortical activity 
to higher frequencies was also observed. It was also found that green tea, a known powerful 
antioxidant (Guo et al. 1996; Frei and Higdon 2003) could diminish these neuro-functional 
alterations in rats receiving intratracheal MnO2 NP exposure (Sárközi et al. 2017). 
Human consequences of long-term Mn exposure are, as outlined above, seen mostly in 
workplace settings. Several processes of metal industry result in generation of metal dusts and 
fumes, with welding as one of the major sources. Welding fume – a typical industrial aerosol 
– is a complex mixture containing solid particles of metal oxides, a significant part of which 
has a diameter below 100 nm, i.e. they are NPs (Antonini et al. 2010). Such particles show 
peculiar physicochemical, and hence, biological and health-related properties, the most 
important being large specific surface area and surface reactivity. Surface reactions generate 
reactive oxygen species (ROS) and may activate various cell surface receptors; at high 
particle number concentration, this leads to great biological and chemical activity 
(Oberdörster et al. 2005). NPs inhaled from a polluted (e.g. workplace) atmosphere are 
typically deposited in the nasopharynx or the alveoli (ICRP 1994) but cause adverse health 
effects also in extrapulmonary organs, resulting from size-dependent high mobility within the 
organism (Oberdörster et al. 2005). Extrapulmonary effects of NPs depend on several factors 
including particle composition and solubility, particle or aggregate size, site of deposition, and 
the integrity of the alveolar epithelial lining (Elder et al. 2006). In rats, NPs of various 
compositions have been detected in the brain after application through the airways (Kreyling 
et al. 2006). Access of NPs to distant body parts after inhalational exposure has been detected 
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also in humans (Theegarten et al. 2010). In welders and other metalworkers, routinely 
exposed to high concentrations of metal fumes, health problems of the nervous system have 
been described (Bowler et al. 2006). NPs in the fumes represent one of the damaging factors 
(Antonini et al. 2003) and their chemical composition, beside size and surface reactivity, is of 
importance. The most common metal elements in the metal parts and welding rods that 
welders are primarily exposed to by metal fume inhalation are Fe, Mn and Cr, followed by 
nickel, silicon, aluminium etc. (Jenkins 2003). 
In the victims of welding-related manganism (Bowler et al. 2006), enhanced magnetic 
resonance imaging (MRI) signal of the basal ganglia, due to deposition of Mn, was found 
(Chang et al. 2010), indicating access of the metal content of the inhaled fumes to the CNS. 
After exposing rats to stainless steel welding fumes (containing Mn, Cr and Fe as well), Park 
et al. (2007) described increased levels of Mn in different brain regions, underlining the 
possible transport of Mn to the brain through the lung/blood circulation.  
The two other major metals in welding fumes, Fe and Cr (the role of which in 
neurotoxicity is much less known), are capable of redox cycling similarly to Mn, and 
contribute this way to oxidative stress (Valko et al. 2005). In case of Fe overload, Fe can 
deposit in certain mitochondria rich organs, and causes disruption of the mitochondrial energy 
production by decreasing enzyme activity (Bacon et al. 1993), resulting in generation of ROS. 
The role of Fe deposited in the basal ganglia in Parkinson’s or Alzheimer’s disease, via a 
mechanism involving oxidative stress, has also been reported (Sayre et al. 1999). 
Occupational exposure to Cr compounds and their respiratory effects have been 
described several times (Derelanko et al. 1999), but information about the neurological effects 
in humans or animals is scarce. In 1941, Lieberman described workers with symptoms of 
dizziness, headache and weakness after excessive inhalation of Cr aerosols. In rats treated 
with sodium chromate, decreased motility was observed (Diaz-Mayans et al. 1986), and 
Repetto et al. (1996) reported Cr3+ toxicity on a neuroblastoma cell line in vitro. Cr2O3 is a 
trivalent Cr oxide compound, often generated in industrial process. Horie et al. (2013) 
reported that cytotoxicity of nanoparticulate (60 nm) Cr2O3 was higher compared to fine 
particles, and that Cr2O3 NPs reduced the mitochondrial activity and released hexavalent Cr in 
the medium. The substance used in the present work, nanoparticulate Cr(OH)3, is the hydrated 
form of Cr2O3. 
Welding as a job affects many people, possibly inducing negative health effects 
including CNS damage, and these effects of welding fumes cannot be assessed based only on 
individual toxicity data of the components. The aim of the present study was thus to 
investigate the general toxicological and CNS electrophysiological effects of nanoparticulate 
Mn, a major component of welding fumes, alone and in combination with Fe and/or Cr, in a 
subacute rat model using intratracheal application. 
Materials and Methods 
Experimental Animals and Substances 
Fifty-four 9 weeks old male Wistar rats (260−280 g body weight at start) were obtained from 
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the university’s breeding center. The animals were housed in standard polypropylene cages 
with a stainless steel top grill, with up to four rats in one cage, under GLP-equivalent 
conditions (22±1 ºC, 30−60% relative humidity, 12-h light/dark cycle with light on at 06:00), 
and had free access to tap water and standard rodent pellet. The rats were randomly divided 
into 7 treatment groups (as shown in Table 1), and were allowed one week for acclimatization 
before the treatment period. 
The rats were exposed to the heavy metal containing NPs by intratracheal instillation 
in daily doses of 2 mg/kg b. w. (with MnO2 NPs, also in 4 mg/kg b. w. daily dose). Calculated 
with the respiratory minute volume of Wistar rats in our age range (based on physiological 
data by Filho et al. 2014), 0.5 m3/kg b. w. ventilation volume is supposed for a rat for 8 hours. 
Based on this data, the intratracheal NP dose of 2 mg/kg corresponds to 4 mg/m3 (and 
intratracheal dose of 4 mg/kg to 8 mg/m3) atmospheric concentration in continuous 8-hour 
(occupational) exposure. The American Conference of Governmental Industrial Hygienists’ 
threshold limit value-time weighted average (ACGIH TLV-TWA) for manganese fume (as 
Mn) is 0.2 mg/m3 (ACGIH, 2012); for iron oxide, it is 5.0 mg/m3 (ACGIH, 2006); and for 
chromium (III), 0.5 mg/m3 (ACGIH, 1991). In a survey published by Korczynski (2000), the 
Mn levels in workplace air polluted by welding fumes ranged from 0.01 to 4.93 mg/m3, while 
iron ranged from 0.04 to 16.29 mg/m3. The applied doses thus relate to possible daily 
occupational exposures, and can be compared to the TLV-TWA values, concentrations to 
which workers are exposed on the basis of a 8 h/day, 40 h/week work schedule, without 
adverse health effects. 
Intratracheal instillation was carried out in brief diethyl ether anesthesia, based on the 
method of Oka et al. (2006). The anaesthetized rat was put on a tilted board (60° to 
horizontal) hanging with the upper incisors in a wire loop, and the larynx was illuminated 
transdermally by means of a fiber optic light guide placed against the animal’s neck. The 
larynx and trachea was visualized using a custom-made laryngoscope to gain access to the 
glottis. The tongue was pulled forward with a pair of non-traumatic forceps, and the 
suspension of the NPs (or the vehicle) was instilled into the trachea by means of a 1 ml 
syringe connected to a thin plastic tube (1.2 mm OD) inserted between the vocal chords. 
Instillation volume was 1 ml/kg b. w. Treatment was performed once a day, 5 times per week, 
for 4 weeks (for daily doses, see Table 1). Our previous experience (Horváth et al. 2012) 
showed that the nervous system effects of NP form of Mn (and other metals) would develop 
in 4 weeks, but animal loss would be minimal. 
In case of the combination groups (see Table 1), Fe3O4 and MnO2 NPs were both 
suspended in the polyacrylic acid (PAA) medium and could be administered together (for 
preparation of the nanosuspensions, see below). However, Cr(OH)3 NPs were suspended in 
normal saline and had to be instilled separately. Administration of NPs in different vehicles 
(combinations containing Cr: MC and MFC) was separated in time by 4 hours in order to 
decrease burden put on the lungs by the instillation (that is, to avoid the administration of 
double volume). An untreated control (Cont) and a vehicle control (VC) group was also used 
because of the expectable own effects of the treatment procedure. The VC group was treated 
with PAA and then normal saline (with 4-hour delay), using the same regime as with the NP-
treated groups. 
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[Table 1 near here] 
Synthesis and Characterization of the Nanoparticles  
The NPs of MnO2, Fe3O4 and Cr(OH)3 were synthesized at
 the Department of Physical 
Chemistry and Materials Science, University of Szeged, Faculty of Science and Informatics. 
For MnO2 NPs, an aqueous alkaline medium containing PAA (MW: 5000) and 
ethanol was prepared and stoichiometric amount of KMnO4 solution was dripped into it under 
stirring. A sol containing MnO2 NPs was generated, the concentration and pH of which was 
adjusted as desired with high purity water and HCl. For vehicle control, the starting medium 
was completed with KOH and NaOH, and pH was set to ca. 7. The method of preparation was 
based on the United States Patent 5268408 (Milner 1993). 
Fe3O4 NPs were generated in a concentrated solution of ferrous and ferric chloride by 
adding NaOH in 10% excess slowly, then suddenly under vigorous stirring. The resulting 
black suspension was washed from residual alkali, then acidified strongly to induce 
peptization. Fe3O4 NPs were stabilized with PAA, and NaCl, HCl and NaOH solutions were 
used to adjust pH 6.5. The procedure, characterization and stability of the Fe3O4 NPs were 
described in details by Hajdú et al. (2012). 
Cr(OH)3 NPs were also generated by alkali treatment (based on the method described 
by Demchak and Matijević et al. 1969), this time in a CrCl3 solution at boiling temperature. 
After cooling, pH was set to 4.11, and the solution was reheated for aging the precipitate 6 
hours long. The precipitate was repeatedly washed by centrifuging and resuspending in 
ultrapure (UP) water until peptization took place. For administration, pH was set to 6.0 and 
concentration was adjusted. Each nanosuspension was freshly prepared each Monday, and 
was sonicated once per week in an ultrasonic bath to maintain its stability. 
The NPs were characterized using transmission electron microscopy (TEM) and 
dynamic light scattering (DLS). For TEM imaging, highly diluted aqueous NP suspensions 
were deposited on carbon-coated copper grids (EMS CF200-Cu) and were air-dried. TEM 
micrographs were taken using a JEOL JEM 1400+ transmission electron microscope with 80 
kV accelerating voltage. Size distribution was determined by evaluating approximately 100 
particles using the JMicroVision 1.2.7 software (Roduit [date unknown]).  
DLS measurements were performed using a NanoZS apparatus (Malvern, UK) with 
the laser beam  = 633 nm produced by a He-Ne laser, operating in back-scattering mode at 
an angle of 173°. The measuring cell (DTS 1060) was used to determine both hydrodynamic 
size distribution and charge state of nanoparticles dispersed in aqueous media. The 
measurements were performed at 25 ± 0.1 °C. Stock suspensions were diluted by UP water 
obtained from Zeener water puriﬁcation system (HumanCorp, Korea), then their pH was 
adjusted to ca. 6.5 by addition of dilute NaOH/HCl. Solid content of the samples was about 
0.1 mg/ml and their ionic strength was low (0.05 to 1.6 mmol/l). Size determination was run 
first, then the electrophoretic mobility of NPs was measured. Size data were calculated from 
the fitted correlation functions assuming that translational diffusion was the dominant 
dynamics and the Stokes-Einstein equation could be used. The instrument was calibrated by 
measuring the zeta potential of a zeta-standard (55 ± 5 mV) supplied by Malvern, which 
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reports an accuracy of ±5 mV. The Smoluchowski equation was applied to convert the 
electrophoretic mobility to zeta potential values. 
 
General Toxicological Investigations 
The body weight of the animals was measured every day during the experiment. From these 
data, the exact daily NP doses were calculated, and weekly body weight gain was determined, 
separately for each rat. Body weight gain (the difference of body weight on Friday of the 
given week and Friday of the pre-treatment week calculated in percentages) was averaged 
group by group, and used as an indicator of general toxicity. Following electrophysiological 
recording (at the end of the 4-week treatment period; see below), the animals were sacrificed 
by an overdose of urethane and were dissected. Blood was collected from the abdominal vein, 
brain and lungs were removed, and the samples were stored at -22 °C in microcentrifugation 
vials and polyethylene self-sealing bags, respectively. 
Tissue levels of Mn, Fe and Cr (possibly indicating the presence of the administered 
NPs) were determined in three rats’ samples by group, chosen randomly. About 1 g samples 
of blood, brain and lungs were dried at 80 °C to constant weight, and were digested in 5 ml 
65% HNO3 at 90 °C for 90 min. The digested matter was diluted 100-fold, and metal levels 
were determined by inductively coupled plasma mass spectrometry at the Laboratory of the 
MOL Hungarian Oil and Gas Company. 
Electrophysiological Recording 
Preparation and electrophysiological recording was performed under urethane anesthesia 
(1000 mg/kg b.w. intraperitoneally; Koblin 2002). The rats’ left hemisphere was surgically 
exposed by removing the parietal bone and a thin layer of petroleum jelly was applied on the 
dura to prevent drying (for details of preparation, see Oszlánczi et al. 2011).  
For recording, the head of the rat was fixed in the stereotaxic frame of the 
electrophysiological setup. A thermostated (+36.5 °C) base plate was used to support the rat’s 
underside and to stabilize body temperature during the recording procedure. Ball-tipped silver 
recording electrodes were placed on the dura over the primary somatosensory (SS) projection 
area of the whiskery pad, and over the primary visual (VIS) and auditory (AUD) focuses. The 
locations were determined on the basis of a somatotopic map (Zilles 1985), and the fine 
positioning of the electrodes was done by searching for the punctum maximum of the evoked 
response. A stainless steel clamp was attached to the cut skin edge as indifferent electrode. 
Spontaneous electrical activity (electrocorticogram, ECoG) was recorded for 6 min. 
From that, the relative spectral power of the frequency bands (delta, theta, alpha, beta1, beta2, 
gamma; standard human EEG bands as described by Kandel and Schwartz (1985) was 
determined. “ECoG index” was calculated from the relative band power data with the formula 
([delta]+[theta])/([beta1]+[beta2]). This proved to be a handy, albeit simplifying, descriptor of 
the ECoG spectrum in earlier works (Dési and Nagymajtényi 1999). 
Then, sensory EPs were elicited and recorded. For SS EPs, square electric pulses were 
given through a pair of needles inserted into the whiskery skin (3−4 V; 0.05 ms). VIS 
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stimulation was performed by flashes delivered by a high-luminescence white LED directly 
into the contralateral eye of the rat. For AUD stimulation, clicks (ca. 40 dB) were applied into 
the contralateral ear of the rat from a mini earphone through the hollow ear bar of the 
stereotaxic frame. From each modality, one series of 50 stimuli was applied at 1 Hz 
frequency, and onset latency of the recorded EPs was measured after averaging. For the SS 
EPs, frequency dependence of the latency was determined by delivering one series of stimuli 
to the whisker pad also with 2 and 10 Hz frequency, beyond the standard 1 Hz. Previous 
studies (Papp et al. 2001) demonstrated that, by varying the frequency of stimulation, the 
dynamic interaction of successive excitation processes in the sensory system can be assessed, 
which in turn reflects the actual state of the CNS. The complete recording and evaluation was 
performed by the software NEUROSYS 1.11 (Experimetria Ltd., Hungary). 
Compliance with Ethical Standards 
During the whole study, the principles of the Ethical Committee for the Protection of Animals 
in Research of the University were strictly followed. The methods used in the experiments 
were licensed by the authority competent in animal welfare issues under No. XXI./151/2013. 
Data Analysis 
Normality test of data was done by the Kolmogorov-Smirnov test, then significance was 
tested with one-way ANOVA with post-hoc LSD test (IBM SPSS Statistics 22.0). Linear 
regression calculations between tissue metal levels and general- and neurotoxicological 
parameters were done by the “linear fit” function of MS Excel. The level of significance was 
set to p<0.05. 
Results 
Characteristics of the nanoparticles 
The TEM images (Figure 1) show morphology and size of NPs. The MnO2 NPs are very 
small, the spherical Fe3O4 crystals are clearly distinguishable and the Cr(OH)3 NPs are in the 
cloud of the amorphous part of this solid. Size distribution of NPs is shown in Figure 2A. The 
smallest MnO2 NPs are of uniform size, while the primary particles of mainly amorphous 
Cr(OH)3 show very broad size distribution.  
The dilute sols were in stable colloidal state, no sedimentation of NPs was observed. 
The measured average sizes and size distributions are characteristic of hydrodynamic units 
moving freely in the given aqueous media. Volume weighted size distribution of NPs at 
pH~6.5 and low salt content are shown in Figure 2B. The shape of distribution curves is 
similar to that in Figure 2A; however, the size ranges from DLS are ca. one order of 
magnitude larger than those observed by TEM. This is because TEM images show the size of 
primary cores of NPs, while DLS detects translational diffusion of particles which are coated 
with hydrate shell and adsorbed small or macro ions forming a steric and/or electric 
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stabilizing layer around the cores. These hydrodynamic units may be aggregates of some 
primary cores. 
The charge state of NPs in aqueous medium at pH ~6.5 was characterized by the sign 
and magnitude of measured zeta potential. For the Cr(OH)3 NPs (uncoated, suspended in UP 
water) zeta potential was +29.6 mV (these NPs carry positive charges due to the protonation 
of surface hydroxyls at pH~6.5). The PAA coated NPs had negative zeta potential 
(Fe3O4:-44.4 mV, MnO2: -24.2 mV; negative charge from dissociated -COOH groups in the 
coating shell at pH~6.5. All measured zeta potentials were sufficiently far from zero to 
provide for a stable colloidal suspension. 
[Figure 1 and 2 near here] 
Body Weight Gain and Metal Levels in Tissue Samples 
Body weight gain of the animals treated with the metal NPs was significantly attenuated 
compared to the untreated control (Cont) from the first treatment week on (Figure 3). 
Decreased body weight gain was also seen in the vehicle control group (VC was significant 
vs. Cont), reflecting the effect of the treatment procedure (mainly the repeated diethyl ether 
anesthesia). Treatment with low (MnLD) and high doses (MnHD) of MnO2 NPs significantly 
decreased body weight gain compared to VC during the treatment period, especially in case of 
MnHD, where weight loss was seen at the end of the first week of the treatment period. In 
case of the combination treatments, MF was not significantly different from VC, but 
combinations containing Cr NPs (MC and MFC) showed significantly lower body weight 
gain. Diminished weight gain was more expressed after treatment with the double 
combination MC than after the triple combination MFC.  
[Figure 3 near here] 
As shown by the data in Table 2, intratracheal instillation of metal NPs caused 
significant increase in the metal content of the tissue samples. In the lungs (at the site of NP 
entry) significant metal deposition was seen in case of MnO2, Fe3O4 and Cr(OH)3 NPs as 
well, while in the blood and brain no elevation of Fe levels was seen compared to VC or Cont. 
On the contrary, significant increase of blood Mn levels was seen in all treatment groups 
(MnLD, MnHD and MF vs. Cont and VC; MC and MFC vs. Cont). In case of treatment with 
combinations containing Cr(OH)3 NPs, significant increase was seen in blood Cr levels (MC 
and MFC vs. Cont and VC), however, only a slight elevation occurred in the Cr content of the 
brain samples. Mn levels measured in the brain were increased in each treatment group 
exposed to MnO2 NPs (MnLD, MnHD, MF, MC and MFC vs. Cont and VC). 
[Table 2 near here] 
By plotting the calculated body weight gain, and Mn levels measured in brain and 
blood samples, against the total applied Mn amount (calculated summed external dose in 
Table 3) for individual rats chosen for metal level measurement (3 per group, see Methods) 
one can see that the effect of the same Mn dose on the body weight gain was influenced by 
the other metal(s) applied (Figure 4A). In treatment groups exposed to Fe3O4 NPs (MF and 
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MFC) the body weight gain was generally less reduced than in Mn-only and MC groups (the 
phenomenon can also be seen on the weight gain data presented in Figure 3). Although 
attenuated body weight gain caused by the combination treatments led to significantly lower 
summed external Mn doses in MC, MFC and MF groups (Table 3) than in MnLD, the internal 
Mn levels measured in brain samples of rats in groups MC and MFC were higher than in 
MnLD, while those measured in blood samples were lower than in MnLD (Figure 4B, 4C; 
Table 2). 
The correlation of metal level in blood and lungs to body weight gain was also 
significant (data not shown). 
[Table 3 near here] 
[Figure 4 near here] 
Cortical Electrical Activity 
In the spectral distribution of the ECoG, the proportion of the fast bands (beta1, beta2 and 
gamma) increased, while that of the slow bands (theta and delta) decreased upon metal NP 
treatment (Figure 5). In the SS ECoG, significant decrease of the delta band and increase of 
the gamma band was caused by Mn-only treatment (vs. Cont and VC). In the combinations 
MC and MFC, these changes were also significant, though less pronounced. The proportion of 
bands changed minimally in group MF (vs. Cont and VC). The observed alterations on the 
VIS ECoG (Figure 5) were similar to those of the SS ECoG, except that MnHD increased the 
proportion of fast bands more significantly, and the combination MF also caused significant 
increase of the gamma band. The effect of MnHD was similarly significant on the AUD 
ECoG, but only MC treatment led to significant increase of the gamma band (vs. Cont and 
VC). 
Figure 6 shows significant correlation of the SS, VIS and AUD ECoG index (see 
Methods) to brain Mn levels in case of low (MnLD) and high dose (MnHD) MnO2 NP 
treatment. 
[Figure 5 near here] 
[Figure 6 near here] 
The SS EPs (Figure 7A) showed significantly increased latency on the action of MnO2 
NPs and of MC combination (and slightly of MFC, but it was significant exclusively at 2 Hz). 
The latency increase was seen at all stimulation frequencies, and the frequency dependent 
extra lengthening (an indication of the actual state of the sensory pathway) was also altered by 
Mn-only and MC treatments. The magnitude of latency increase was the highest in case of 
MC, while in group MF, no change was observed compared to VC. Changes in the VIS and 
AUD latencies were similar to SS EPs, i.e. significant increase was seen in case of MnLD and 
MnHD treatments, and partly in MC, vs. VC, but not in MF (Figure 7B).  
[Figure 7 near here] 
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[Figure 8 near here] 
When SS cortical EP latencies were plotted against brain Mn levels, significant 
correlation of latency data from low and high dose MnO2 NP treatment to brain Mn levels 
was found at all stimulation frequencies (Figure 8 shows correlation of data at 10 Hz 
stimulation frequency; this represents maximal strain to the sensory pathway within the 
applied protocol at which any functional damage due to the treatment may be more 
conspicuous). Figure 8 also shows that SS EP latency data of rats receiving the MC and MFC 
combinations were increased compared to MnLD, while those in the MF group were 
decreased. This phenomenon was in agreement with the data shown in Figure 7, namely that 
Cr(OH)3 plus MnO2 NPs together (MC) had effects similar to Mn-only treatment; however, 
when Fe3O4 NPs were added to MnO2 NPs (MF and MFC), there was only a slight or no 
change of latency vs. VC. In case of VIS and AUD EPs, the relationship of latency and inner 
Mn doses in the various treated groups was similar (data not shown). 
 
Discussion 
Our results indicated interactions between the applied metals in the general and nervous 
system effects which were not paralleled by the corresponding internal doses. The most 
conspicuous phenomenon concerning body weight gain as general toxicity parameter was the 
apparent protective role of Fe3O4 NP co-treatment, seen in the weekly (Figure 3) and overall 
(Table 3) weight gain data, up to significantly less reduction of body weight gain in group MF 
vs. MnHD. Presence of Cr(OH)3 NPs had no such effect, and diminished weight gain was 
more expressed after treatment with the double combination (MC) than after the triple 
combination (MFC). The correlation plots of the calculated body weight gain, and of the Mn 
levels in brain and blood samples, against the total applied Mn amount also reflected the 
diminished effect of Mn on body weight in presence of Fe (Figure 4A) without altering 
internal Mn doses (Figure 4B, 4C). 
Of the two kinds of cortical activity recorded, EPs reflect alterations in synaptic 
transmission and axonal conduction more directly. Figure 7 shows that the latency of EPs was 
longer, and the extra latency lengthening of SS EP on higher frequency stimulation (2 or 10 
Hz vs. 1 Hz; Figure 7A) was increased, in the Mn-only and MC combination groups 
compared to VC, but the difference of MF vs. VC was minimal. The increase in frequency-
dependent latency lengthening (a possible indicator of neuro-functional damage: Papp et al. 
2001) could reflect impaired synaptic transmission and/or the consequences of oxidative 
stress and energetic shortage. 
The efficacy of transmission is likely to be deteriorated as Mn2+ ions partly block 
presynaptic Ca channels, but also penetrate them, and cause intracellular Ca mobilization 
(Kita et al. 1981) which will decrease synchronous, but promote spontaneous, release of 
transmitters. In the case of Cr2+, a similar effect in the adrenal medulla was described (Liu and 
Lin 1997). The ion channel effects of the metals could affect both synaptic transmission and 
axonal conduction. 
The main excitatory transmitter in the CNS is glutamate. After being released into the 
synaptic cleft and having activated the receptors, glutamate is taken up and converted to 
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glutamine by the astrocytes. Mn2+ decreases both its uptake (Erikson and Aschner 2003) and 
transformation to glutamine (Normandin and Hazell 2001). Accumulation of excess glutamate 
at all transmission sites of the ascending sensory pathways may have resulted over the 4 
weeks of exposure in receptor desensitization, possibly contributing to increased EP latency 
(Centonze et al. 2001). Excess glutamatergic activity could have also contributed to the 
observed increase of cortical activation (shift of the ECoG to higher frequencies), via the 
glutamatergic collaterals from the specific afferents to the ascending reticular formation. 
The properties of the three metals (see Introduction) suggested the role of oxidative 
stress and/or mitochondrial damage in the mechanism of the observed effects. Mn is a well-
documented mitochondrial toxin, acting on complex II (Malecki 2001) and complex III 
(Zhang et al. 2003). Cr in the mitochondria oxidizes NADH and inhibits alpha-ketoglutarate 
dehydrogenase (Cohen et al. 1993). In mitochondrial Mn-SOD, surplus Fe tends to replace 
Mn, decreasing enzyme activity (Bacon et al. 1993). Fenton reaction, a redox cycle 
characteristic for all three metals studied (Valko et al. 2005) can generate hydroxyl radicals 
within the mitochondria. The resulting oxidative stress could be responsible both for reduced 
body weight gain (due to the metabolic disturbance caused by free radicals: Merry 2002) and 
the neuro-functional effects. Generation of ROS in the brain has been reported with Mn 
(Zhang et al. 2009), Fe (Sayre et al. 1999) and Cr (Soudani et al. 2012). Peroxidation of 
membrane lipids leads to changes of fluidity and other properties which, in turn, disturb all 
membrane- and receptor-bound phenomena, such as synaptic transmission. 
As seen in Figure 5 to Figure 8, the change of electrophysiological parameters was 
proportional to the relevant internal Mn load in the Mn-only groups, similar to the body 
weight effect; but was diminished in group MF, and partly in MFC, at comparable internal 
Mn levels. The diminishing action of Fe on the damage caused by Mn was hence not due to 
reduced presence of Mn in blood and brain, despite the common route of transport by 
transferrin into cells and through the BBB (Mn: Takeda 2003; Fe: Thompson et al. 2001; Cr: 
Vincent 2001). The method used to determine metal levels in biological samples in the 
present work did not distinguish between physicochemical forms (NPs or dissolved ions) but 
dissolution of the metal oxide NPs, at least partly, was likely (in the highly acidic lysosomes 
of phagocytes: Lundborg et al. 1985). 
The interactions seen at the level of toxic effects and of internal dose were thus dissimilar; 
first of all, presence of Fe diminished the action of Mn on body weight and 
electrophysiological indicators without an effect on the internal Mn doses and, moreover, 
without an increase of brain Fe content (see Table 2). Instead, Fe possibly induced protective 
reactions with a more general effect. In cultured astrocytes (Gaasch et al. 2007) high 
dissolved Fe load stimulated induction of ferritin and downregulation of the transferrin 
receptor. This not only reduced transferrin-dependent uptake of Mn and Cr also but the 
stimulated astrocytes induced increased antioxidant defense in the nearby neurons, too. Lin et 
al. (2014) treated rat kidney-derived cells (NRK-52E) with Fe3O4 NPs similar to ours and 
observed induction of anti-apoptotic protective proteins (glutathione reductase, glutathione-S-
transferase, chaperon proteins). It seems conceivable that protective cellular reactions induced 
by Fe provide protection against Mn and Cr which have similar mechanisms of action. Such 
an effect would probably depend on the doses of the metals. In the present study, equal doses 
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of the different NPs were administered to compare general toxicological and nervous system 
electrophysiological effects of welding fume NP exposure under identical treatment 
conditions. To overcome this limitation, it is a task for the future to investigate the interaction 
of the three metals using doses that represent the composition of real welding fumes. 
 
Conclusion 
The results described and evaluated above underline that the biological effects of complex 
metal exposures cannot be understood from the effects of the individual metals only. Animal 
models like the one used in the present study provide essential information for better 
understanding of such complex exposures, and, indirectly, for higher level of occupational 
hygiene. 
Limitations of the study 
Pulmonary toxicity of the applied NPs was not studied in the present experiment. In a future 
work histopathological evaluation and bronchoalveolar lavage analysis should be carried out 
to improve the evaluation of toxic effects. 
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Table 1. Treatment groups and daily doses. 
Group code Dose and treatment (/kg b.w.) n 
Cont untreated control 6 
VC 1 ml PAA + 1 ml normal saline; vehicle control 8 
MnLD 2 mg MnO2; low dose 8 
MnHD 4 mg MnO2; high dose 8 
MF 2 mg MnO2 + 2 mg Fe3O4; double combination 8 
MC 2 mg MnO2 + 2 mg Cr(OH)3; double combination 8 
MFC 2 mg MnO2 + 2 mg Fe3O4 + 2 mg Cr(OH)3; triple combination 8 
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Table 2. Metal levels in blood, brain and lung samples. 
 Tissue metal levels (μg/kg) 
 
Cont VC  MnLD  MnHD MF MC MFC 
B
lo
o
d
 
Fe  
2298240.75 
± 20150.90 
2249378.68 
± 396766.73 
− − 
2369477.75 
± 58384.64 
− 
2324487.14 
± 52554.01 
Mn 
278.84 
± 79.56 
309.41 
± 97.19 
533.44 
± 99.94*# 
715.21 
± 176.01*# 
530.46 
± 79.46*# 
432.76 
± 37.21* 
436.16 
± 22.51* 
Cr 
142.90 
± 16.06 
138.71 
± 10.67 
− − − 
639.85 
± 107.24**## 
520.85 
± 165.54*# 
B
ra
in
 
Fe  
85243.51 
± 3719.38 
80222.65 
± 9683.69 
− − 
82831.18 
± 10200.72 
− 
80890.50 
± 5209.78 
Mn 
2010.17 
± 354.19 
1897.94 
± 289.96 
5548.28 
± 518.42***### 
8159.31 
± 673.97***###°° 
5495.31 
± 512.58***### 
6183.42 
± 495.33***### 
6351.18 
± 671.70***### 
Cr 
122.70 
± 15.01 
146.84 
± 42.40 
− − − 
277.04 
± 180.34 
200.26 
± 94.02 
L
u
n
g
s 
Fe  
386146.30 
± 27269.51 
347220.77 
± 61025.06 
− − 
9933993.95 
± 3392692.31**## 
− 
7693587.62 
± 934597.04***### 
Mn 
1256.71 
±417.31 
1550.57 
± 279.68 
11739.03 
± 458.71***### 
11747.39 
± 7547.83 
6947.20 
± 2134.28*# 
8696.07 
± 1321.46***### 
10162.93 
± 2215.36**## 
Cr 
215.45 
± 34.95 
179.54 
± 33.43 
− − − 
7862358.03 
± 960490.48***### 
5162283.66 
± 489893.10***### 
Mean±SD, n=3 
*, **, *** p < 0.05, 0.01, 0.01 vs. Cont; #, ##, ### p < 0.05, 0.01, 0.001 vs. VC 
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Table 3. Body weight gain over the 4 weeks of metal NP exposure, and summed metal dose 
calculated for the same period. 
 Body weight gain (g) Calculated summed external metal load (mg/rat) 
Groups  Mn  Fe Cr 
Cont 150.17±12.83 − − − 
VC 111.1±19.02*** − − − 
MnLD 71.8±13.35***### 8.15±0.45 − − 
MnHD 37.67±24.18***###°° 14.96±1.24°°° − − 
MF 115.56±19.79** 7.22±0.45°°° 2.76±0.17 − 
MC 89.3±20.35***# 7.15±0.35°°° − 5.71±0.28 
MFC 102.13±15.06*** 6.48±1.7°° 2.48±0.65 5.18±1.35 
Mean±SD, n=8. **, *** p < 0.01, 0.001 vs. Cont; #, ### p < 0.05, 0.001 vs. VC; °°, °°° p < 0.01, 0.001 
vs. MnLD 
The summed external metal load was calculated by adding individual daily doses which were 
calculated on the basis of daily body weights, group doses given in Table 1, and metal content of 
the NPs according to their formula. 
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Figure 1. 
TEM images of MnO2 (top), Fe3O4 (middle) and Cr(OH)3 (bottom) NPs. 
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Figure 2. 
A: Evaluation of TEM images to compare size and size distribution of the different NPs dried 
on the TEM grid from their dilute sols. Average diameters of primary MnO2, Fe3O4 and 
Cr(OH)3 NPs are 3.6, 8.8 and 13.5 nm, respectively. Size distributions were calculated from 
evaluating approximately 100 particles. B: Volume weighted size distribution of NPs in dilute 
aqueous sols at pH~6.5. 
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Figure 3. 
Body weight gain of the rats during the 4 weeks of metal NP exposure. Mean+SD, n=8.  
Weekly body weight gain − as the difference of body weight on Friday of the given week and 
Friday of the pre-treatment week − was calculated in percentage separately for each rat, then 
averaged group by group. Insert: weeks of exposure. 
*, **, *** p < 0.05, 0.01, 0.001 vs. Cont; #, ##, ### p < 0.05, 0.01, 0.001 vs. VC; °, °°, °°° p < 
0.05, 0.01, 0.001 vs. MnLD. 
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Figure 4. 
Correlation of body weight gain (A), and of brain (B) and blood (C) Mn levels (ordinate) to 
summed external Mn dose (abscissa). Each point represents a data pair from an individual rat 
chosen for metal level measurement (see Methods).  
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Light symbols, Cont; light grey symbols, VC; dark grey symbols, MnLD; black symbols, 
MnHD. Patterned symbols indicate combinations of NPs: squares, MF; circles, MC; triangles, 
MFC. Inserts: equation and R2 of the line fitted on Cont, MnLD, MnHD points; *: p < 0.05 (F-
test for the linear fit). 
 
Figure 5. 
Power spectrum of the ECoG from the three cortical areas after 4 weeks of exposure to metal 
NPs. Abscissa, groups; ordinate, relative power of ECoG bands (see insert). 
*, ** p < 0.05, 0.01 vs. Cont; #, ## p < 0.05, 0.01 vs. VC. 
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Figure 6. 
Correlation of SS, VIS and AUD ECoG index (ordinate) to brain Mn levels (abscissa). Each 
point represents a data pair (see insert at the bottom for corresponding sensory modality) from 
an individual rat chosen for metal level measurement (see Methods).  
Light symbols, Cont; light grey symbols, VC; dark grey symbols, MnLD; black symbols, 
MnHD. Inserts with outlines corresponding to the fitted lines: equation and R2; *: p < 0.05 (F-
test for the linear fit). 
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Figure 7. 
Latency of the SS (A), and VIS and AUD (B) cortical evoked potentials. Relative values, 
normalized to the latency in group VC (for the somatosensory EPs, to the latency obtained 
with 1 Hz stimulation, see insert in A). This figure shows latency data in relative values, 
normalized to the latency of the SS EP obtained with 1 Hz stimulation in the VC group. Data 
of the untreated control (Cont) are not displayed because the difference between Cont and VC 
was negligible.  
Mean+SD, n=8. *, **, ***: p < 0.05, 0.01, 0.001 vs. VC (for the SS EPs, at identical 
stimulation frequency). &, &&, &&&: for SS EPs, p < 0.05, 0.01, 0.001 vs. 1 Hz stimulation 
within the same group. 
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Figure 8. 
Correlation of the latency of the SS EPs (ordinate) to brain Mn levels (abscissa). 
Each point represents a data pair from an individual rat chosen for metal level measurement 
(see Methods). Light symbols, Cont; light grey symbols, VC; dark grey symbols, MnLD; 
black symbols, MnHD. Patterned symbols indicate combinations of NPs: squares, MF; circles, 
MC; triangles, MFC. Inserts: equation and R2; *: p < 0.05 (F-test for the linear fit). 
 
 
